Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
3.920
-0.150 (-3.69%)
At close: Jan 8, 2026, 4:00 PM EST
3.890
-0.030 (-0.77%)
Pre-market: Jan 9, 2026, 8:02 AM EST
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $103.89 million as of January 9, 2026. Its market cap has increased by 71.13% in one year.
Market Cap
103.89M
Enterprise Value
88.60M
1-Year Change
71.13%
Ranking
Category
Stock Price
$3.92
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $103.89M, an increase of 66.20%. That is a compound annual growth rate of 8.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 107.87M | 17.63% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.50B |
| Johnson & Johnson | 500.89B |
| AbbVie | 402.59B |
| UnitedHealth Group | 312.90B |
| AstraZeneca | 297.23B |
| Merck & Co. | 275.80B |
| Novartis AG | 273.49B |
| Novo Nordisk | 254.60B |